A Q3 2019 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$32B

Q3 2019 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.3B+5.9% YoY

Gross Profit

$692M54.3% margin

Operating Income

$225M17.7% margin

Net Income

$191M15.0% margin

EPS (Diluted)

$0.60

QoQ Revenue Growth

+2.9%

Cash Flow

Operating Cash Flow

$242M

Free Cash Flow

$194M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$8.6B

Total Liabilities

$3.9B

Stockholders' Equity

$4.7B

Cash & Equivalents

$1.8B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.3B	$1.2B	+5.9%
Gross Profit	$692M	$661M	+4.7%
Operating Income	$225M	$216M	+4.2%
Net Income	$191M	$236M	-19.1%

Revenue Segments

Life Sciences and Applied Markets

$544M43%

Agilent CrossLab

$467M37%

Diagnostics and Genomics

$263M21%

Geographic Segments

Asia Pacific

$470M37%

Americas

$465M36%

Europe

$339M27%